INFINITY PHARMACEUTICALS
Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, in multiple clinical studies. MARIO-275 is a global, randomized, placebo-controlled study of eganelisib combined with Opdivo® in I/O naïve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is... evaluating eganelisib in combination with Tecentriq® and Abraxane® in front-line TNBC and in combination with Tecentriq and Avastin® in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (dual adenosine receptor antagonist) plus Doxil® in advanced TNBC patients. With these studies Infinity is evaluating eganelisib in the anti-PD-1 refractory, I/O-naïve, and front-line and second line settings.
INFINITY PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.infi.com
Total Employee:
51+
Status:
Active
Contact:
617-453-1000
Email Addresses:
[email protected]
Total Funding:
538.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Apache
Similar Organizations
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
BioRelix
BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Neurocrine Biosciences
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
ULURU
ULURU engages in the research, development, and commercialization of wound care and mucoadhesive film products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
BVF Partners
BVF Partners investment in Post-IPO Equity - Infinity Pharmaceuticals
Deerfield
Deerfield investment in Post-IPO Debt - Infinity Pharmaceuticals
Purdue Pharma
Purdue Pharma investment in Post-IPO Equity - Infinity Pharmaceuticals
Mundipharma
Mundipharma investment in Post-IPO Debt - Infinity Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Infinity Pharmaceuticals
Purdue Pharma
Purdue Pharma investment in Venture Round - Infinity Pharmaceuticals
Amgen Ventures
Amgen Ventures investment in Venture Round - Infinity Pharmaceuticals
Wellcome Trust
Wellcome Trust investment in Series B - Infinity Pharmaceuticals
Vulcan Medical Ventures
Vulcan Medical Ventures investment in Series B - Infinity Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Infinity Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-07 | Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors |
Official Site Inspections
http://www.infi.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.59 K
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Infinity Pharmaceuticals"
INFI - Crunchbase Company Profile & Funding
INFI is located in Chicago, Illinois, United States. Who are INFI 's competitors? Alternatives …See details»
infi.com Reviews: Is this site a scam or legit? – Scam Detector
Organization Media Worx, LLC . Street 1309 Coffeen Avenue STE 1200, Sheridan, Wyoming, …See details»
Infinity Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number 617-453-1000 Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially first-in …See details»
INFI Company Profile 2024: Valuation, Funding & Investors
INFI General Information Description. Developer of a cloud-based platform intended to enable …See details»
INFI MultiChain - Crunchbase Company Profile
With our advanced cybersecurity measures, INFI CDEX is safeguarded. We prioritize investor safety through effective liquidity management and swift …See details»
1100 Massachusetts Avenue Cambridge, MA 02138 Tel: (617) 453 …
1100 Massachusetts Avenue Floor 4 Cambridge, MA 02138 Tel: (617) 453-1000 Fax: (617) …See details»
infi.com - Whois.com
Sep 29, 1999 Whois Lookup for infi.com. Login Sign up My Account Logout; Domains. …See details»
Infi - Overview, News & Similar companies | ZoomInfo.com
Infi is a company that operates in the Internet industry. It employs 11-20 people and has $1M …See details»
Infinity Pharmaceuticals (INFI) Profile - The Globe and Mail
Mar 23, 2010 See the company profile for Infinity Pharmaceuticals (INFI) including business …See details»
Infi Company Profile - Office Locations, Competitors, Revenue
Infi Summary. Company Summary. Overview. Infi is a company that develops software …See details»
MEI Pharma and Infinity Pharmaceuticals Announce Definitive …
Feb 23, 2023 Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) is a clinical-stage biotechnology …See details»
InfiCONSOLE-en | INFI
159 N Sangamon St. Suite 200 office 251, Chicago, IL, 60607. General Terms & Conditions. …See details»
INFI - Company Profile - Tracxn
Dec 16, 2024 INFI - Provider of SaaS based robotic kiosks for restaurants. Raised funding …See details»
Infinity Pharmaceuticals (INFI) Statistics - The Globe and Mail
Find out all the key statistics for Infinity Pharmaceuticals (INFI), including valuation measures, …See details»
Infi Strategies
InFi Strategies is an innovative investment strategy consultancy committed to delivering …See details»
infiBond - Crunchbase Company Profile & Funding
Doing something vs merely WHAT they are currently doing, enabling INFI's clients to …See details»
InFI Careers and Employment | Indeed.com
Aug 20, 2018 Find out what works well at InFI from the people who know best. Get the inside …See details»
www.infi.com
Www.infi.comSee details»
INFI New YORK
INFI New York proudly collaborated with Ki Smith Gallery for an inspiring event supporting …See details»
Why INFI ? | INFI
Success With INFI. Boost Customer Loyalty and Marketing. Enhance how you keep and attract …See details»